Personality, Serotonin, and Noradrenaline

On the Psychobiology of Personality: Essays in Honor of Marvin Zuckerman

Volumn , Issue , 2004, Pages 379-408

  Hennig, J ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84875057473     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-008044209-9/50021-X     Document Type: Chapter

References (106)

1. Abelson J.L., Glitz D., Cameron O.G., Lee M.A., Bronzo M., Curtis G.C. Endocrine, cardiovascular and behavioural responses to clonidine in patients with panic disorder. Biological Psychiatry 1992, 32:18-25.
2. Amin A.H., Crawford B.B., Gaddum J.H. Distribution of 5-hydroxytryptamine and substance P in central nervous system. Journal of Physiology, London 1954, 126:596-618.
3. Apter A., Plutchik R., van Praag H.M. Anxiety, impulsivity and depressed mood in relation to suicidal and violent behavior. Acta Psychiatrica Scandinavica 1993, 87:1-5.
4. Asberg M., Traskman L., Thoren P. 5-HIAA in the cerebrospinal fluid: A biochemical suicide predictor?. Archives of General Psychiatry 1976, 33:1193-1197.
5. Aston-Jones G. Behavioral functions of locus coeruleus derived from cellular attributes. Physiological Psychology 1985, 13:118-126.
6. Aston-Jones G., Ennis M., Pieribone V.A., Nickell W.T., Shipley M.T. The brain nucleus locus coeruleus: Restricted afferent control of a broad efferent network. Science 1986, 234:734-737.
7. Ballenger J.C. Biochemical correlates of personality traits in normals: An exploratory study. Personality and Individual Differences 1983, 4:615-625.
8. Baumgarten H.G., Grozdanovic Z. Die Rolle des Serotonins in der Verhaltensmodulation. Fortschritte der Neurologie-Psychiatrie [Advances of Neuropsychiatry] 1995, 63:3-8.
9. Baumgarten H.G., Grozdanovic Z. Psychopharmacology of central serotonergic systems. Pharmacopsychiatry 1995, 28:73-79.
10. Berridge C.W., Arnsten A.F.T., Foote S.L. Noradrenergic modulation of cognitive function: Clinical implications of anatomical, electrophysiological and behavioral studies in animal models. Psychological Medicine 1993, 23:557-564.
11. Blakely R.D., Baumann A.L. Biogenic amine transporters: Regulation in flux. Current Opinion in Neurobiology 2000, 10:328-336.
12. Blaschko H. The specific action of L-dopa carboxylase. Journal of Physiology 1939, 96:50-51.
13. Blier P., de Montigny C. Differential effect of gepirone on presynaptic and postsynaptic serotonin receptors; single cell recording studies. Journal of Clinical Psychopharmacology 1990, 10:13-20.
14. Blizzard D. The locus coeruleus: A possible neural focus for genetic differences in emotionality. Experientia 1988, 44:491-495.
15. Blombery P.A., Kopin I.J., Gordon E.K., Markey S.P., Ebert M.H. Conversion of MHPG to vanillylmandelic acid: Implications for the importance of urinary MHPG. Archives of General Psychiatry 1980, 37:1095-1098.
16. Bond A.J. Neurotransmitters, temperament and social functioning. European Neuropsychopharmacoly 2001, 11:261-274.
17. Bremner J.D., Krystal J.H., Southwick S.M., Charney D.S. Noradrenergic mechanisms in stress and anxiety: II. Clinical studies. Synapse 1996, 23:39-51.
18. Calhoon-La Grange L.L., Don Jones T., Reyes E., Ott S. Monoamine oxidase levels in females: Relationships to sensation seeking, alcohol misuse, physical fitness, and menstrual cycle. Personality and Individual Differences 1993, 14:439-446.
19. Cannon W.B., Uridil J.E. Studies on the conditions of activity in endocrine glands. VIII. Some effects on the denervated heart of stimulating the nerves of the liver. American Journal of Physiology 1921, 58:353-354.
20. Carlsson A., Corrodi H., Fuxe K., Hokfelt T. Effect of antidepressant drugs on the depletion of intraneural brain 5-hydroxytryptamine stores caused by 4-methyl-a-ethyl-meta-tyramine. European Journal of Pharmacology 1969, 5:357-366.
21. Cloninger C.R., Przybeck T.R., Svrakic D.M. The Tridimensional Personality questionnaire: U.S. normative data. Psychological Reports 1991, 69:1047-1057.
22. Cloninger C.R., Przybeck T.R., Svrakic D.M., Wetzel R.D. The temperament and character inventory (TCI): A guide to its development and use 1994, Center for Psychobiology and Personality, St. Louis, MO.
23. Cloninger C.R., Svrakic D.M., Przybeck T.R. A psychobiological model of temperament and character. Archives of General Psychiatry 1993, 50:975-990.
24. Coccaro E.F. Impulsive aggression and central serotonergic system function in humans: An example of a dimensional brain-behavior relationship. International Journal of Clinical Psychopharmacology 1992, 7:3-12.
25. Coccaro E.F., Lawrence T., Trestman R., Gabriel S., Klar H.M., Siever L.J. Growth hormone responses to intravenous clonidine challenge correlate with behavioral irritability in psychiatric patients and healthy volunteers. Psychiatry Research 1991, 39:129-139.
26. Coccaro E.F., Siever L.J., Klar H.M., Maurer G., Cochrane K., Cooper T.B., Mohs R.C., Davis K.L. Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior. Archives of General Psychiatry 1989, 46:587-599.
27. Curtin F., Walker J.-P., Peyrin L., Sulier V., Badan M., Schulz P. Reward Dependence is positively related to urinary monoamines in normal men. Biological Psychiatry 1997, 42:275-281.
28. Dahlström A., Fuxe K. Evidence for the existence of monoamine neurons in the central nervous system. I. Demonstration of monoamines in cell bodies of brain stem neurons. Acta Physiologica Scandinavia, Supplement 1964, 232:1-55.
29. Deakin J.F.W., Crow T.J. Monoamines, reward and punishment-the anatomy and physiology of the affective disorders. The biology of depression 1986, 1-25. Gaskell Press, London. J.F.W. Deakin (Ed.).
30. Depue R.A. Neurobiological factors in personality and depression. European Journal of Personality 1995, 9:439.
31. Depue R.A., Collins P.F. Neurobiology of the structure of personality: Dopamine, facilitation of incentive motivation, and extraversion. Behavioral Brain Sciences 1999, 22:491-517.
32. Ebstein R.P., Segman R., Benjamin J., Osher Y., Nemanov L., Belmaker R.H. 5-HT2C (HTR2C) serotonin receptor gene polymorphism associated with the human personality trait of reward dependence: Interaction with dopamine D4 receptor (D4DR) and dopamine D3 receptor (D3DR) polymorphisms. American Journal of Medical Genetics 1997, 74:65-72.
33. Eysenck H.J., Eysenck S.B.G. Manual of the Eysenck Personality Questionnaire 1975, Hodder & Stoughton, London.
34. Farnebo L.O., Hamberger B., Jonsson G. Release of (3 H)noradrenaline and (3 H)dopamine from field stimulated cerebral cortex slices. Effect of tyrosine hydroxylase and dopamine-hydroxylase inhibition. Journal of Neurochemistry 1971, 18:2491-2500.
35. Flament M.F., Rapoport J.L., Murphy D.L., Berg C.J., Lake C.R. Biochemical changes during clomipramine treatment of childhood obsessive-compulsive disorder. Archives of General Psychiatry 1987, 44:219-255.
36. Fuxe K. Evidence for the existence of monoamine neurons in the central nervous system. IV. The distribution of monoamine terminals in the central nervous system. Acta Physiologica Scandinavia, Supplement 1965, 247:41-85.
37. Garvey M.J., Noyes R., Cook B., Blum N. Preliminary confirmation of the proposed link between reward-dependence traits and norepinephrine. Psychiatry Research 1996, 65:64.
38. Gerra G., Avanzini P., Zaimovic A., Sartori R., Bocchi C., Timpano M., Zambelli U., Delsignore R., Gardini F., Talarico E., Brambilla F. Neurotransmitters, neuroendocrine correlates of sensation seeking temperament in normal humans. Neuropsychobiology 1999, 39:207-213.
39. Gerra G., Caccavari R., Marcato A., Zaimovic A., Avanzini P., Monica C., Mutti A., Fontanesi B., Delsignore R., Brambilla F. Alpha-1- and-2-adrenoceptor subsensitivity in siblings of opioid addicts with personality disorders and depression. Acta Psychiatrica Scandinavia 1994, 90:269-273.
40. Gerra G., Zaimovic A., Timpano M., Zambelli U., Delsignore R., Brambilla F. Neuroendocrine correlates of temperamental traits in humans. Psychoneuroendocrinology 2000, 25:479-496.
41. Goodwin G.M., Murray C.L., Bancroft J. Oral d-fenfluramine and neuroendocrine challenge: Problems with the 30 mg dose in men. Journal of Affective Disorders 1994, 30:117-122.
42. Haller J., Makara G.B., Kruk M.R. Catecholaminergic involvement in the control of aggression: Hormones, the peripheral sympathetic and central noradrenergic systems. Neurosciences and Biobehavioral Reviews 1998, 22:85-97.
43. Hansenne M., Ansseau M. Harm avoidance and serotonin. Biological Psychology 1999, 51:77-81.
44. Hennig J. Serotonin und Persönlichkeit. Zeitschrift für Differentielle und Diagnostische Psychologie 2000, 21:226-234.
45. Hennig J., Becker H., Netter P. 5-HT agonist-induced changes in peripheral immune cells in healthy volunteers: The impact of personality. Behavioral Brain Research 1996, 73:359-363.
46. Hennig J., Lange N., Haag A., Rohrmann S., Netter P. Reboxetine in a neuroendocrine challenge paradigm: Evidence for high cortisol responses in healthy volunteers scoring high on subclinical depression. International Journal of Neuropsychopharmacology 2000, 3:193-201.
47. Hennig J., Laschefski U., Becker H., Rammsayer T., Netter P. Immune cell and cortisol responses to physically and pharmacologically induced lowering of body core temperature. Neuropsychobiology 1993, 28:82-86.
48. Hennig J., Netter P. Oral application of citalopram (20mg) and its usefulness for neuroendocrine challenge tests. International Journal of Neuropsychopharmacology 2002, 5:67-71.
49. Hennig J., Opper C., Huwe S., Netter P. The antagonism of ipsapirone induced biobehavioral responses by +/- pindolol in high and low impulsives. Journal of Neural Transmission 1997, 104:1027-1035.
50. Hennig J., Toll C., Schonlau P., Rohrmann S., Netter P. Endocrine responses after d-fenfluramine and ipsapirone challenge: Further support for Cloninger's tridimensional model of personality. Neuropsychobiology 2000, 41:38-47.
51. Higley J.D., Mehlman P.T., Poland R.E., Taub D.M., Vickers J.H., Suomi S.J., Linnoila M. CSF testosterone and 5-HIAA correlate with different types of aggressive behaviors. Biological Psychiatry 1996, 40:1067-1082.
52. Holtz P. Über die sympathikomimetische Wirksamkeit von Gehirnextrakten. Acta Physiologica Scandinavia 1950, 20:354-362.
53. Izzo J.L., Horwitz D., Keiser H.R. Reduction of human urinary MHPG excretion by guanethidine: Urinary MHPG as index of sympathetic nervous activity. Life Sciences 1979, 24:1403-1406.
54. Katsuragi S., Kunugi H., Sano A., Tsutsumi T., Isogawa K., Nanko S., Akiyoshi J. Association between serotonin transporter gene polymorphism and anxiety-related traits. Biological Psychiatry 1999, 45:368-370.
55. Klinteberg B., Schalling D., Edman G., Oreland L., Asberg M. Personality correlates of platelet monoamine oxidase (MAO) activity in female and male subjects. Neuropsychobiology 1987, 18:89-96.
56. von Knorring A., Hallman J., von Knorring L., Oreland L. Platelet monoamine oxidase activity in type 1 and type 2 alcoholism. Alcohol and Alcoholism 1991, 26:409-416.
57. Knutson B., Wolkowitz O.M., Cole S.W., Chan T., Moore E.A., Johnson R.C., terpstra J., Turner R.A., Reus V.L. Selective alteration of personality and social behavior by serotonergic intervention. American Journal of Psychiatry 1998, 155:373-379.
58. Lai S., Tolis G., Martin J.B., Brown G.M., Guyda H. Effect of Clonidin on growth hormone, prolactin, luteinizing hormone, follicle-stimulating hormone and thyroid stimulating hormone in the serum of normal men. Journal of Clinical Endocrinology and Metabolism 1975, 41:827-832.
59. 1A receptor activation in humans. European Journal of Clinical Pharmacology 1990, 39:17-19.
60. Lesch K.P., Rupprecht R., Poten B., Muller U., Sohnle K., Fritze J., Schulte H.M. Endocrine responses to 5-hydroxytryptamine-1A receptor activation by ipsapirone in humans. Biological Psychiatry 1989, 26:203-205.
61. Lopez I.J.J., Saiz R.J., Iglesias L.M. The fenfluramine challenge test in the affective spectrum: A possible marker of endogeneity and severity. Pharmacopsychiatry 1988, 21:9-14.
62. Malone K.M., Thase M.E., Mieczkowski T., Myers J.E., Stull S.D., Cooper T.B., Mann J.J. Fenfluramine challenge test as a predictor of outcome in major depression. Psychopharmacology Bulletin 1993, 29:155-161.
63. Mazzanti C.M., Lappalainen J., Long J.C., Bengel D., Naukkarinen A., Eggert M., Virkkunen M., Linnoila M., Goldmann D. Role of the serotonin transporter promotor polymorphism in anxiety related traits. Archives of General Psychiatry 1998, 55:940.
64. Möller S.E., Mortensen E.L., Breum L., Alling C., Larsen O.G., Boge-Rasmussen T., Jensen C., Bennicke K. Aggression and personality: Association with amino acids and monoamine metabolites. Psychological Medicine 1996, 26:323-331.
65. Mongeau R., Blier P., de Montigny C. The serotonergic and noradrenergic systems of the hippocampus: Their interactions and the effects of antidepressant treatments. Brain Research and Brain Research Reviews 1997, 23:145-195.
66. Moresco F.M., Dieci M., Vita A., Messa C., Gobbo C., Galli L., Rizzo C., Panzacchi A., De Peri L., Invernizzi G., Fazio F. In vivo serotonin 5-HT2a receptor binding and personality traits in healthy subjects: A positron emission tomography study. Neuroimage 2002, 17:1470-1478.
67. Murphy D.L., Belmaker R.H., Buchsbaum M.S., Martin N.F., Ciaranello R., Wyatt R.J. Biogenic amine related enzymes and personality variations in normals. Psychological Medicine 1977, 7:149-157.
68. Nelson E., Cloninger C.R. Exploring the TPQ as a possible predictor of antidepressant response to nefazodone in a large multi-site study. Journal of Affective Disorders 1997, 44:197-200.
69. Nelson R.J., Chiavegatto S. Molecular basis of aggression. Trends in Neuroscience 2001, 24:713-719.
70. Netter P., Hennig J., Roed S. Serotonin and dopamine as mediators of sensation seeking. Neuropsychobiology 1996, 34:155-165.
71. Peirson A.R., Heuchert J.W., Thomala L., Berk M., Plein H., Cloninger C.R. Relationship between serotonin and the temperament and character inventory. Psychiatry Research 1999, 89:29-37.
72. 3H]-spiroperidol. Molecular Pharmacology 1979, 16:687-699.
73. Plouffe L., Stelmack R.M. Neuroticism and the effect of stress on the pupillary light reflex. Perceptual and Motor Skills 1979, 49:635-642.
74. Power A.C., Cowen P.J. Neuroendocrine challenge tests: Assessment of 5-HT function in anxiety and depression. Molecular Aspects in Medicine 1992, 13:205-220.
75. van Praag H.M. Faulty cortisol/serotonin interplay. Psychopathological and biological characterisation of a new, hypothetical depression subtype (SeCA depression). Psychiatry Research 1996, 65:143-157.
76. van Praag H.M., Korf J., Schut D. Cerebral monoamines and depression. Archives of General Psychiatry 1973, 28:827-831.
77. Quabeck M., Lehmann E., Tegeler J. Comparison of the antidepressant action of tryptophan, tryptophan/5-Hydroxytryptophan combination and nomifensine. Neuropsychobiology 1984, 11:111-115.
78. Rainbow T.C., Parsons B., Wolfe B.B. Quantitative autoradiography of beta 1- and beta 2-adrenergic receptors in rat brain. Proceedings of the National Academy of Sciences, U.S.A. 1984, 81:1585-1589.
79. Ricketts M.H., Hamer R.M., Sage I.J., Manowitz P., Feng F., Menza M.A. Association of a serotonin transporter gene promotor polymorphism with harm avoidance behaviour in an elderly population. Psychiatry Genetics 1998, 42:1129.
80. Rowland N.E., Carlton J. Neurobiology of an anoretic drug: Fenfluramine. Progress in Neurobiology 1986, 27:62.
81. Roy A., Adinoff B., Roehrich L., Lamparski D., Custer R., Lorenz V., Barbaccia M., Guidotti A., Costa E., Linnoila M. Pathological gambling. A psychobiological study. Archives of General Psychiatry 1988, 45:369-373.
82. Roy A., Linnoila M. Suicidal behavior, impulsiveness and serotonin. Acta Psychiatrica Scandinavia 1988, 78:529-535.
83. Roy A., Linnoila M. CSF studies on alcoholism and related behaviours. Progress in Neuropsychopharmacology and Biological Psychiatry 1989, 13:505-511.
84. Ruegg R.G., Gilmore J., Ekstrom R.D., Corrigan M., Knight B., Tancer M., Leatherman M.E., Carson S.W., Golden R.N. Clomipramine challenge responses covary with tridimensional personality questionnaire scores in healthy subjects. Biological Psychiatry 1997, 42:1129.
85. Schalling D., Asberg M. Biological and psychological correlates of impulsiveness and monotony avoidance. The biological bases of personality and behavior: Theories, measurement techniques, and development 1985, Vol. 1:181-194. Hemisphere Publishing, Washington, DC. J. Strelau, F.H. Farley, A. Gale (Eds.).
86. Schildkraut J.J. The catecholamine hypothesis of affective disorders: A review of supporting evidence. American Journal of Psychiatry 1965, 122:509-522.
87. Schooler C., Zahn T.P., Murphy D.L., Buchsbaum M.S. Psychological correlates of monoamine oxidase in normals. Journal of Nervous and Mental Diseases 1978, 166:177-186.
88. Seibyl J.P., Krystal J.H., Price L.H., Woods S.W., D'Amico C., Heninger G.R., Charney D.E. Effects of Ritanserin on the behavioral, neuroendocrine, and cardiovascular responses to meta-chlorophenyl-piperanzine in healthy human subjects. Psychiatry Research 1991, 38:227-236.
89. Siever L.J., Coccaro E.F., Zemishlany Z., Silverman J., Klar H., Losonczy M.F., Davidson M., Friedman R., Mohs R.C., Davis K.L. Psychobiology of personality disorders: Pharmacologic implications. Psychopharmacology Bulletin 1987, 23:333-336.
90. Stahl S.M. Platelets as pharmacological models for the receptors and biochemistry of monoaminergic neurons. The platelets: Physiology and pharmacology 1985, 307-340. Academic Press, New York. G.L. Longenecker (Ed.).
91. Storlien L.H., Smythe G.A. D-fenfluramine effects on hypothalamic monoamine activities and their hormonal correlates. Brain Research 1992, 597:60-65.
92. Sumner B.E., Fink G. Testosterone as well as estrogen increases serotonin 2A receptor mRNA and binding site densities in the male rat brain. Brain Research and Molecular Brain Research 1998, 59:205-214.
93. Tancer M.E., Ranc J., Golden R.N. Pharmacological challenge test of the Tridimensional Personality Questionnaire in patients with social phobia and normal volunteers. Anxiety 1994, 1:224-226.
94. Tellegen A. Structures of mood and personality and their relevance to assessing anxiety, with an emphasis on self-report. Anxiety and anxiety disorders 1985, 681-706. Erlbaum, Hillsdale, NJ. A.H. Tuma, J.D. Maser (Eds.).
95. Twarog B.M., Page I.H. Serotonin content of some mamalian tissues and urine and an method for its determination. American Journal of Physiology 1953, 175:157-161.
96. Vogt M. The concentration of sympathin in different parts of the central nervous system under normal conditions and after the administration of drugs. Journal of Physiology 1954, 123:451-481.
97. Wilson K.M., Minneman K.P. Regional variations in alpha 1-adrenergic receptor subtypes in rat brain. Journal of Neurochemistry 1989, 53:1782-1786.
98. Winblad B., Gottfries C.-G., Oreland L., Wilberg A. Monoamine oxidase in human platelets and brain of non-neurological geriatric patients. Medical Biology 1979, 57:129-132.
99. Wingrove J., Bond A.J., Cleare A.J., Sherwood R. Trait hostility and prolactin response to tryptophan enhancement/depletion. Neuropsychobiology 1999, 40:202-206.
100. Yatham L.N., Steiner M. Neuroendocrine probes of serotonergic function: A critical review. Life Sciences 1993, 53:447-463.
101. Young W., Laws E., Sharbrough F., Weinshilboum R.M. Human monoamine oxidase. Lack of brain and platelet correlation. Archives of General Psychiatry 1986, 43:604-609.
102. Zald D.H., Depue R.A. Serotonergic modulation of positive and negative affect in psychiatrically healthy males. Personality and Individual Differences 2001, 30:71-86.
103. Zuckerman M. The psychophysiology of sensation seeking. Journal of Personality 1990, 58:313-358.
104. Zuckerman M. Psychobiology of personality 1991, Cambridge University Press, Cambridge.
105. Zuckerman M. P-impulsive sensation seeking and its behavioral, psychophysiological and biochemical correlates. Neuropsychobiology 1993, 28:30-36.
106. Zuckerman M., Kolin E.A., Price L., Zoob I. Development of a sensation seeking scale. Journal of Consulting Psychology 1964, 28:477-482.